KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Accumulated Expenses (2019 - 2025)

LifeMD filings provide 7 years of Accumulated Expenses readings, the most recent being $6.3 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses fell 31.57% to $6.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.3 million, a 31.57% decrease, with the full-year FY2025 number at $6.3 million, down 31.57% from a year prior.
  • Accumulated Expenses hit $6.3 million in Q4 2025 for LifeMD, up from $3.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $14.9 million in Q2 2025 to a low of $405459.0 in Q3 2021.
  • Median Accumulated Expenses over the past 5 years was $6.3 million (2025), compared with a mean of $7.4 million.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 18949.79% in 2021 and later tumbled 96.13% in 2022.
  • LifeMD's Accumulated Expenses stood at $11.6 million in 2021, then tumbled by 96.13% to $448718.0 in 2022, then surged by 3006.07% to $13.9 million in 2023, then plummeted by 34.35% to $9.1 million in 2024, then crashed by 31.57% to $6.3 million in 2025.
  • The last three reported values for Accumulated Expenses were $6.3 million (Q4 2025), $3.2 million (Q3 2025), and $14.9 million (Q2 2025) per Business Quant data.